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Successful implantation of dental implants depends not
only on the implant material, but is also significantly
affected by the immunologic status of the organism. The
most problematic here is chronic low grade inflammation
which increases with the age (i.e., immunaging). This type
of inflammation differs from classical acute inflammation
by the absence of clinical symptoms and specific activation
of monocytes in the circulation and tissue macrophages.
Highly specific and sensitive biomarkers for detection of
this inflammatory condition are urgently needed. In our
laboratory, we have identified several biomarkers that are
expressed by macrophages differentiated in the microen-
vironment typical for chronic low grade inflammation.
These markers include receptors Stabilin-1 and IL17RB,
and transcription factor FoxQ1. Stabilin-1 is a multifunc-
tional macrophage receptor responsible for scavenging of
unwanted self products and for sorting of newly synthe-
sized ligands and facilitating their secretion. These func-
tions of Stabilin-1 indicate that it is not only a marker, but
also actively involved in the regulation of inflammatory
reactions. IL17RB is a receptor for IL17E – the sole mem-
ber of IL17 family that is not involved in regulation of type
1 inflammation, but rather mediating low grade type 2
inflammation. FoxQ1 is a transcription factor of forkhead
family. The entire family is actively involved in regulation
of innate and adaptive immune reactions including the
development of regulatory T-cell phenotype. Our data
indicate that FoxQ1 is typical for macrophages showing
increased adhesion and migration capabilities, making
them active players in low grade inflammation in tissues.
All above mentioned biomarkers are expressed by mono-
cytes/macrophages upon stimulation with IL-4 or
in combination with TGFb and/or IFNg- cytokines playing
important role in chronic low grade inflammation.
Association of Stabilin-1, FoxQ1 and IL17RB with chronic
low grade inflammation makes them not only viable per-
sonalized diagnostic markers, but also suggests their use-
fulness as targets for development of novel personalized
therapeutic options. We propose to use novel biomarkers
of chronic inflammation to predict individual reactions of
patients to implants and as a reference for development of
immunostabilizing therapies to prevent implant failure.
Published: 11 February 2014
doi:10.1186/1878-5085-5-S1-A116
Cite this article as: Kzhyshkowska et al.: Novel biomarkers of hidden
inflammation and implantation. EPMA Journal 2014 5(Suppl 1):A116.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: julia.kzhyshkowska@medma.uni-heidelberg.de
Medical Faculty Mannheim, Ruprecht-Karls University of Heidelberg, Theodor-
Kutzer Ufer 1-3, 68167, Mannheim, Germany
Kzhyshkowska et al. EPMA Journal 2014, 5(Suppl 1):A116
http://www.epmajournal.com/content/5/S1/A116
© 2014 Kzhyshkowska et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
